Effects of pulsatile intravenous insulin therapy on the progression of diabetic nephropathy

Metabolism: Clinical and Experimental

Volumn 49, Issue 11, 2000, Pages 1491-1495

  Dailey, George E ^{a,b,c,d,e,f,g,h}   Boden, Guenther H ^{a,b,c,d,e,f,g,h}   Creech, Robert H ^{a,b,c,d,e,f,g,h}   Johnson, David G ^{a,b,c,d,e,f,g,h}   Gleason, Ray E ^{a,b,c,d,e,f,g,h}   Kennedy, Frank P ^{a,b,c,d,e,f,g,h}   Weinrauch, Larry A ^{a,b,c,d,e,f,g,h}   Weir, Matthew ^{a,b,c,d,e,f,g,h}   D’Elia, John A ^{a,b,c,d,e,f,g,h}  

^a SCRIPPS CLINIC   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

^c Medical Center   (United States)

^d UNIVERSITY OF ARIZONA MEDICAL CENTER   (United States)

^e Joslin Clinic   (United States)

^f MAYO CLINIC   (United States)

^g MOUNT AUBURN HOSPITAL   (United States)

^h UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PULSATILE DRUG RELEASE;

EID: 0033756157     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2000.17700     Document Type: Article

References (28)

1. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study
2. Diabetic nephropathy
3. Diabetic nephropathy
4. Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes
5. High glucose concentration causes a decrease in mesangium degradation
6. Long term correction of hyperglycemia and progression of renal failure in insulin-dependent diabetes
7. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus
8. Progression of diabetic nephropathy in normotensive type 1 diabetic patients
9. Monitoring glomerular function in diabetic nephropathy
10. Slope of serial glomerular filtration rate and the progression of diabetic glomerular disease
11. The effect of angiotensinconverting-enzyme inhibition on diabetic nephropathy
12. Improved survival in patients with diabetic nephropathy
13. Effect of antihypertensive treatment on kidney function in diabetic nephropathy
14. Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type 1 diabetic humans
15. Greater efficacy of pulsatile insulin in type 1 diabetics critically depends on plasma glucagon levels
16. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
17. Long-term intermittent intravenous insulin therapy and type I diabetes mellitus
18. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy
19. Effect of intensive insulin therapy on progression of overt nephropathy in patients with type 1 diabetes mellitus
20. Progression of chronic renal failure in man
21. Effect of improved metabolic control on loss kidney function in type 1 (insulin-dependent) diabetic patients: An update of the Steno studies
22. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
23. The relationship between long-term glycemic control and diabetic nephropathy
24. Impact of metabolic control on progression of clinical diabetic nephropathy
25. Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria
26. Effect of chronic intermittent intravenous insulin therapy on antihypertensive medication requirements in IDDM subjects with hypertension and nephropathy
27. Hyperglycemia and diabetic kidney disease: The case for transforming growth factor β as a key mediator